<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, because various physical distancing measures in response to COVID‐19 are anticipated to remain in place for the foreseeable future, PWUD may have difficulty accessing healthcare services, including opioid substitution therapy, medication‐assisted treatment and other substance use treatment services. Telemedicine has been successfully implemented during other global emergencies [
 <xref rid="jia225551-bib-0023" ref-type="ref">23</xref>] and presents a key opportunity for helping PWUD stay connected to services while protecting themselves against COVID‐19 infection. PWUD in greatest need will require sustained access to technology that allows them to leverage telemedicine to facilitate engagement with critical healthcare services, including continuous contact with counsellors and addiction medicine specialists. In Canada, opioid substitution therapy is prescribed and administered through daily dispensing at pharmacies or as a take‐home medication [
 <xref rid="jia225551-bib-0024" ref-type="ref">24</xref>]. During the COVID‐19 pandemic some governments have recommended home delivery of HIV medications [
 <xref rid="jia225551-bib-0025" ref-type="ref">25</xref>]; similar considerations for opioid substitution therapy and medication‐assisted treatment may be possible in certain contexts. Uninterrupted access to cellular and internet service will also be crucial to the success of these programmes.
</p>
